Bank of America’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6K | Sell |
10,510
-3,230
| -24% | -$4.49K | ﹤0.01% | 6096 |
|
|
2025
Q1 | $13.5K | Buy |
13,740
+1,990
| +17% | +$1.96K | ﹤0.01% | 6019 |
|
|
2024
Q4 | $15.4K | Sell |
11,750
-909
| -7% | -$1.19K | ﹤0.01% | 5986 |
|
|
2024
Q3 | $43.5K | Buy |
12,659
+2,405
| +23% | +$8.27K | ﹤0.01% | 5690 |
|
|
2024
Q2 | $33.8K | Sell |
10,254
-12,565
| -55% | -$41.5K | ﹤0.01% | 5752 |
|
|
2024
Q1 | $107K | Buy |
22,819
+1,194
| +6% | +$5.62K | ﹤0.01% | 5363 |
|
|
2023
Q4 | $158K | Buy |
21,625
+13,657
| +171% | +$99.7K | ﹤0.01% | 5286 |
|
|
2023
Q3 | $96.3K | Sell |
7,968
-1,050
| -12% | -$12.7K | ﹤0.01% | 5388 |
|
|
2023
Q2 | $95.4K | Sell |
9,018
-8,436
| -48% | -$89.3K | ﹤0.01% | 5375 |
|
|
2023
Q1 | $172K | Sell |
17,454
-243,432
| -93% | -$2.4M | ﹤0.01% | 5220 |
|
|
2022
Q4 | $3.84M | Buy |
260,886
+247,926
| +1,913% | +$3.65M | ﹤0.01% | 3126 |
|
|
2022
Q3 | $158K | Buy |
12,960
+1,770
| +16% | +$21.6K | ﹤0.01% | 5314 |
|
|
2022
Q2 | $157K | Sell |
11,190
-20,231
| -64% | -$284K | ﹤0.01% | 5486 |
|
|
2022
Q1 | $448K | Sell |
31,421
-452
| -1% | -$6.45K | ﹤0.01% | 5200 |
|
|
2021
Q4 | $672K | Buy |
31,873
+8,459
| +36% | +$178K | ﹤0.01% | 4880 |
|
|
2021
Q3 | $615K | Buy |
23,414
+18,570
| +383% | +$488K | ﹤0.01% | 4707 |
|
|
2021
Q2 | $151K | Sell |
4,844
-15,451
| -76% | -$482K | ﹤0.01% | 5499 |
|
|
2021
Q1 | $622K | Buy |
20,295
+19,356
| +2,061% | +$593K | ﹤0.01% | 4591 |
|
|
2020
Q4 | $32K | Buy |
+939
| New | +$32K | ﹤0.01% | 5705 |
|